Worldwide Markets for Small Molecule Drug Discovery to 2026: Key Analyses & Forecasts - ResearchAndMarkets.com
The "Small Molecule Drug Discovery - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
According to this report, the Global Small Molecule Drug Discovery Market is expected to grow at a CAGR of 8.5% during the forecast period.
Some of the factors such as rise in drug discovery and development and rising usage of these drugs in the treatment of chronic diseases are driving the market growth. However, high costs of drugs are hindering the market growth.
By Process Phase, lead optimization segment held significant growth during the forecast period due to increasing strength, selectivity, or pharmacokinetic parameters, rising in cancer and other diseases encouraging investments in lead optimization.
Based on geography, North America is anticipated to be one of the leading regions contributing to the global market during the forecast period. There is an increasing number of contract organizations for research and development - this shows that the United States is focusing on R&D activities to meet the rising demands of its people, finally leading the market of North America.
Process Phases Covered:
- Hit Generation and Selection
- Lead Identification
- Lead Optimization
- Target ID/Validation
Therapeutic Areas Covered:
- Central Nervous System
- Other Therapeutic Areas
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb
- Gilead Sciences Inc.
- Johnson & Johnson
- Merck & Co.
- Pfizer Inc
- Teva Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/research/6s85mz/worldwide_markets?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20190118005242/en/